ES2065034T3 - Sistema compuesto molecular para la terapia contraescalativa de las enfermedades infecciosas viricas. - Google Patents

Sistema compuesto molecular para la terapia contraescalativa de las enfermedades infecciosas viricas.

Info

Publication number
ES2065034T3
ES2065034T3 ES91909678T ES91909678T ES2065034T3 ES 2065034 T3 ES2065034 T3 ES 2065034T3 ES 91909678 T ES91909678 T ES 91909678T ES 91909678 T ES91909678 T ES 91909678T ES 2065034 T3 ES2065034 T3 ES 2065034T3
Authority
ES
Spain
Prior art keywords
lpl
plp
units
infectious diseases
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91909678T
Other languages
English (en)
Inventor
Chantal Mach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2065034T3 publication Critical patent/ES2065034T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

LA INVENCION CONCIERNE A UN SISTEMA COMPUESTO MOLECULAR PARA LA QUIMIOTERAPIA RESTITUTIVA DE ENFERMEDADES INFECCIOSAS VIRALES, OBTENIBLE MEDIANTE (I) LA PRODUCCION DE UNIDADES DE LIGNINA RICAS EN POLISACARIDOS (PLP) MEDIANTE: EXTRACCION EN MEDIOS ACUOSOS EN UN MEDIO DEBILMENTE ACIDO HASTA ALCALINO DE MADERA O MATERIALES TIPO MADERA TAMBIEN DE (O) CULTIVOS CELULARES VEGETALES (A); SEPARACION DE LOS COMPONENTES SOLIDOS INSOLUBLES; (II) PRODUCCION DE UNIDADES LIGNOIDES POBRES EN POLISACARIDOS DE BAJO PESO MOLECULAR (LPL) MEDIANTE: EXTRACCION ACUOSO-ALCALINA (PH 7-14) DE PRODUCTOS DE CARBONIZACION DE LA MADERA O MATERIALES TIPO MADERA BIOCONVERTIDOS (B); SEPARACION DE LOS COMPONENTES SOLIDOS INSOLUBLES EN ALCALIS ; (III) PRODUCCION DE UN POLIMERIZADO MIXTO SOLUBLE EN AGUA LD (PLP=LPL) MEDIANTE: TRANSFORMACION DEL PRODUCTO DE LA ETAPA I), LAS UNIDADES DE LIGNINA RICAS EN POLISACARIDOS (PLP) CON LOS PRODUCTOS DE LA ETAPA II), LAS UNIDADES LIGNOIDES POBRES EN POLISACARIDOS (LPL) BAJO CONDICIONES ACUOSO-ALCALINAS (PH 9-12); AISLAMIENTO DE LAS FRACCIONES LD DE ESTE POLIMERIZADO MIXTO HD-PLP=LPL MEDIANTE ULTRAFILTRACION A UNOS VALORES DE CORTE NOMINALES DE APROX. 15 A 40 KD, EN DONDE SE DESECHA EL RETENTADO; TRATAMIENTO DE LA SOLUCION CON UN INTERCAMBIADOR DE CATIONES H+ A UN PH DE 3 HASTA 7,0, ASI COMO TRATAMIENTO POSTERIOR DEL SISTEMA ACIDO LD(LPL-PLP), QUE SE PUEDE APLICAR ESPECIALMENTE COMO SISTEMA DE SUSTANCIAS ACTIVAS INHIBIDORAS DE VIRUS APLICABLE PARENTERAL O LOCALMENTE PARA COMBATIR LAS ENFERMEDADES INFECCIOSAS VIRALES, EN DONDE LOS VIRUS PUEDEN SER RETROVIRUS, ESPECIALMENTE DEL TIPO HIV, TAMBIEN VIRUS DEL SIDA.
ES91909678T 1990-05-27 1991-05-27 Sistema compuesto molecular para la terapia contraescalativa de las enfermedades infecciosas viricas. Expired - Lifetime ES2065034T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4017091A DE4017091A1 (de) 1990-05-27 1990-05-27 Molekuelverbundsystem zur kontra-eskalativen therapie viraler infektionskrankheiten

Publications (1)

Publication Number Publication Date
ES2065034T3 true ES2065034T3 (es) 1995-02-01

Family

ID=6407309

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91909678T Expired - Lifetime ES2065034T3 (es) 1990-05-27 1991-05-27 Sistema compuesto molecular para la terapia contraescalativa de las enfermedades infecciosas viricas.

Country Status (17)

Country Link
US (2) US5554596A (es)
EP (1) EP0535001B1 (es)
JP (1) JP2905289B2 (es)
AT (1) ATE110275T1 (es)
AU (1) AU663684B2 (es)
BG (1) BG61154B1 (es)
CA (1) CA2084093C (es)
DE (2) DE4017091A1 (es)
DK (1) DK0535001T3 (es)
ES (1) ES2065034T3 (es)
FI (1) FI925363A0 (es)
HU (2) HUT68910A (es)
NO (1) NO306049B1 (es)
PL (1) PL168266B1 (es)
RO (1) RO113430B1 (es)
RU (1) RU2104016C1 (es)
WO (1) WO1991018616A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348503B1 (en) 1996-02-12 2002-02-19 Meryl J. Squires Method and topical treatment composition for herpesvirus hominis
US6355684B1 (en) 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
US6350784B1 (en) * 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
DE4236346A1 (de) * 1992-10-28 1994-05-05 Chantal Dr Mach Wirkstoffgruppe, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE4316347C1 (de) * 1993-02-26 1994-08-18 Ina Dr Levi Verfahren zur Herstellung einer pharmazeutischen Zubereitung und Verwendung derselben zur Behandlung bestimmter Erkrankungen
DE4415087A1 (de) * 1994-04-29 1995-11-09 Zschiegner Hans Joachim Dr Mittel als Wirkstoffe bzw. Wirkstoffgemische zur Anwendung in der Balneotherapie, Gesundheitspflege und Kosmetik und Verfahren zur Herstellung pharmazeutischer Erzeugnisse sowie Verfahren zu ihrer Anwendung
DE4417254A1 (de) * 1994-05-17 1995-11-23 Zschiegner Hans Joachim Dr Mittel als Wirkstoffe bzw. Wirkstoffgemische für Tierarzneimittel, Tiergesundheitspflegemittel, Medizinalfuttermittel, Ergotropika und zur Anwendung in der Veterinärhygiene sowie Verfahren zur Herstellung der Mittel und pharmazeutischer Erzeugnisse und Methoden ihrer Anwendung
FR2731162B1 (fr) * 1995-03-01 1997-04-11 Oreal Procede d'extraction d'au moins un actif a partir de cellules vegetales indifferenciees
US20090191288A1 (en) * 1996-02-12 2009-07-30 Squires Meryl J Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases
FR2757046B1 (fr) * 1996-12-16 1999-03-05 Dior Christian Parfums Utilisation d'un extrait de resine d'okoume, dans les domaines cosmetique et pharmaceutique, notamment dermatologiques
GB9806513D0 (en) * 1998-03-26 1998-05-27 Phytopharm Ltd Membrane-bound receptors
US7498156B2 (en) 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US7049110B2 (en) 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
RU2131262C1 (ru) * 1998-10-14 1999-06-10 Плисов Николай Валерьевич Способ получения медицинского лигнина
RU2141335C1 (ru) * 1998-12-30 1999-11-20 Общество с ограниченной ответственностью "Лигфарм" Противоопухолевое средство "олипифат" и способ его получения
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
RU2172176C1 (ru) * 2000-06-19 2001-08-20 Общество с ограниченной ответственностью "Нобель" Способ получения противовирусного средства
RU2276157C2 (ru) * 2000-11-27 2006-05-10 Бомсунд Групо Асесор, С.Л. Полисахарид с иммуностимулирующей активностью, способ его получения и применение
US6866875B2 (en) * 2001-09-26 2005-03-15 Tampa Bay Research Institute Pine cone extracts and uses thereof
US7838046B2 (en) * 2001-09-26 2010-11-23 Tampa Bay Research Institute Plant extracts and uses thereof
US6703053B2 (en) * 2001-10-24 2004-03-09 Tampa Bay Research Institute Anti-HSV agent for inhibiting replication of HSV-1 and HSV-2 and method of producing a substance having anti-HSV activity
RU2199335C1 (ru) * 2001-12-21 2003-02-27 Одинец Алексей Глебович Способ повышения эффективности растительных препаратов
RU2233668C1 (ru) * 2003-05-20 2004-08-10 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Способ получения препарата фенольной природы из растительного сырья
CN1897958B (zh) * 2003-12-24 2011-02-02 特拉维夫大学拉玛特有限公司 从天然肉桂提取物中获得的抗病毒制剂
RU2277099C1 (ru) * 2005-02-14 2006-05-27 Институт биологии Коми научного центра Уральского отделения Российской академии наук Способ получения водорастворимого лигнина
RU2401117C1 (ru) * 2009-04-06 2010-10-10 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Средство для профилактики гриппа и острых респираторных заболеваний
JP2010273569A (ja) * 2009-05-26 2010-12-09 Wasaburo Sato メタボリックシンドローム改善作用を有する飲料及びサプリメント
US20100303935A1 (en) * 2009-05-29 2010-12-02 Squires Meryl J Medicinal Composition

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185097A (en) * 1978-01-09 1980-01-22 A. H. Robins Company, Inc. Method of combating Herpes simplex viruses with lignosulfonates
JPS54154507A (en) * 1978-05-22 1979-12-05 Eisai Co Ltd Inactivating agents for hbs anitgen
ATE7854T1 (de) * 1980-03-12 1984-06-15 Walter Dr. Dipl.-Phys. Mach Neuer biochemischer wirkstoff, verfahren zu seiner herstellung und diesen wirkstoff enthaltende pharmazeutische zubereitung.
JPS5939411B2 (ja) * 1980-12-24 1984-09-22 野田食菌工業株式会社 抗動物ウイルス剤
JPS57130919A (en) * 1981-02-06 1982-08-13 Eisai Co Ltd Lignin-containing virucide
DE3206911A1 (de) * 1982-02-26 1983-09-15 Lohmann Tierernährung GmbH, 2190 Cuxhaven Biochemischer wirkstoff, dessen herstellung und diesen wirkstoff enthaltendes mittel
JPS6072823A (ja) * 1983-09-29 1985-04-24 Chisso Corp 抗ウイルス剤
DE3707909A1 (de) * 1987-03-12 1988-09-22 Ruetgerswerke Ag Niedermolekulare alkalihuminate, verfahren zu ihrer herstellung und verwendung
US4985249A (en) * 1987-06-26 1991-01-15 Hiroshi Sakagami Anti-HIV agents
US4988799A (en) * 1987-08-11 1991-01-29 Daishowa Chemicals Inc. Lignosulfonate based pharmacologic agent with anti-coagulant and anti-thrombotic activity
US4935239A (en) * 1988-04-12 1990-06-19 Sanyo-Kokusaku Pulp Co., Ltd. Composition for antiviral medicines
JP2602715B2 (ja) * 1988-04-12 1997-04-23 日本製紙 株式会社 抗ウィルス性医薬用組成物
CA1335259C (en) * 1989-03-31 1995-04-18 Makoto Machida Composition of spent liquor from pulping process for antiviral medicine
JPH02262524A (ja) * 1989-03-31 1990-10-25 Shozo Toda エイズウイルス増殖抑制剤
JPH02286623A (ja) * 1989-04-27 1990-11-26 Noda Shiyokukin Kogyo Kk 抗ウイルス物質及びその製法
JPH03120223A (ja) * 1989-10-04 1991-05-22 Sanyo Kokusaku Pulp Co Ltd 抗ウイルス性医薬用組成物
JP2923660B2 (ja) * 1990-01-06 1999-07-26 宏 坂上 ウイルス感染防止剤
JP2938916B2 (ja) * 1990-01-10 1999-08-25 日本ケミカルリサーチ株式会社 ヘルペスウィルスの増殖阻害および潜伏感染後の再発阻止剤

Also Published As

Publication number Publication date
AU7892891A (en) 1991-12-31
FI925363A7 (fi) 1992-11-25
HU211541A9 (en) 1995-12-28
RO113430B1 (ro) 1998-07-30
JP2905289B2 (ja) 1999-06-14
RU2104016C1 (ru) 1998-02-10
NO306049B1 (no) 1999-09-13
DE4017091A1 (de) 1991-11-28
US5698524A (en) 1997-12-16
PL168266B1 (pl) 1996-01-31
AU663684B2 (en) 1995-10-19
NO924575D0 (no) 1992-11-26
EP0535001B1 (de) 1994-08-24
CA2084093A1 (en) 1991-11-28
HU9203747D0 (en) 1993-03-29
JPH05507270A (ja) 1993-10-21
WO1991018616A1 (de) 1991-12-12
FI925363A0 (fi) 1992-11-25
NO924575L (no) 1993-01-12
DK0535001T3 (da) 1995-02-20
ATE110275T1 (de) 1994-09-15
HUT68910A (en) 1995-08-28
CA2084093C (en) 2002-10-22
BG61154B1 (bg) 1997-01-31
EP0535001A1 (de) 1993-04-07
DE59102660D1 (de) 1994-09-29
US5554596A (en) 1996-09-10
BG97122A (bg) 1993-12-24

Similar Documents

Publication Publication Date Title
ES2065034T3 (es) Sistema compuesto molecular para la terapia contraescalativa de las enfermedades infecciosas viricas.
RU92016546A (ru) Группа активных веществ для восстановительной химиотерапии
AR038596A1 (es) Sistemas de expresion de virus parainfluenza recombinantes y vacunas que comprenden antigenos heterologos derivados de metapneumovirus
ES2087335T3 (es) Membranas hidrofilas sinteticas y procedimiento para su produccion.
CA2006119C (en) Anti-aids viral agents and anticancer action
ES8205306A1 (es) Un metodo de liofilizacion de una composicion viral acuosa
JPS6429389A (en) Novel physiologically active substance and production thereof
Hafez et al. Humic substances as an environmental-friendly organic wastes potentially help as natural anti-virus to inhibit COVID-19
US20110027240A1 (en) Secretable hiv entry inhibitory peptides for therapy of hiv infection
ATE89735T1 (de) Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.
AR029810A1 (es) Metodos y composiciones para la inhibicion de los acontecimientos asociados con la fusion de membrana, incluyendo la transmision de rsv
ES2099588T3 (es) Proceso para la preparacion de acido n-fosfonometilimino-diacetico.
Amouroux et al. Antiviral activity in vitro of Cupressus sempervirens on two human retroviruses HIV and HTLV
SG170825A1 (en) Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
CN106727623A (zh) 海藻低聚糖在制备抗禽白血病病毒制剂中的应用
BR0017378A (pt) Método para a preparação de extratos aquosos de plantas, extrato aquoso, uso do extrato aquoso e preparação farmacêutica
Yip et al. Antiviral activity of a derivative of the photosensitive compound hypericin
EP0681578A1 (en) AGAINST VIRUSES EFFECTIVE NAPHTOCHINONE COMPOUNDS, COMPOSITIONS AND THEIR USE.
ES8201005A1 (es) Un metodo para producir un producto de cafe soluble
ATE40854T1 (de) Therapeutische zusammensetzungen mit antiviraler wirksamkeit.
JPH03120223A (ja) 抗ウイルス性医薬用組成物
MX164795B (es) Inactivacion mediante fenoles del virus de la inmunodeficiencia humana(hiv),en soluciones con contenido de proteinas
Arsène Lessons for SARS-CoV-2 study (COVID-19 disease) from its exosome relatives
RU2016149795A (ru) Биологически активная синергетическая композиция
CN1058609C (zh) 化合物摩鲁新(morusin)的医药用途

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 535001

Country of ref document: ES